Dr Harold Farber, an associate professor of pediatrics, Pulmonary Section, at the Baylor College of Medicine at Texas Children's Hospital, discusses the new requirement for tobacco companies to publish corrective statements regarding the dangers of their products. More at: www.consultant360.com/pulmonology.